SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

Press Release

Published on 08/04/2022

2 min read

BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBLIC Hotel in New York City. The event will begin at 1:30 p.m. EDT and is expected to conclude at approximately 5:30 p.m. EDT.

The event will feature presentations from the CEO and Co-Founder, Dr. Jurgi Camblong as well as from other members of the executive leadership team, followed by a Q&A session and reception.

Due to limited capacity, advanced registration is required for in-person attendance and is available by invitation. For more information, interested parties may contact Investor Relations at [email protected].

Additionally, the event will be webcast live and all interested parties are invited to access the webcast from the Investor Relations section of the company’s website. A replay of the webcast and slides shown during the presentations will also be available on the company’s website the following day.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on TwitterLinkedIn and Instagram. Where others see data, we see answers

Investor Contact:
Jennifer Pottage
Head of Investor Relations
[email protected]

Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
[email protected]

Sign Up To Our Newsletter

Enter your email address to join our mailing list and receive the latest news and updates from SOPHiA GENETICS. You can unsubscribe by using the link integrated with the communication at any time. By clicking to “sign up”, you agree that SOPHiA GENETICS will process your data in accordance with its Privacy Policy

pink dots icon

Recent Press Releases

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';